Bristol-Myers Squibb Pays $14M Over Alleged China Bribes

By Max Stendahl · October 5, 2015, 1:24 PM EDT

Bristol-Myers Squibb Co. on Monday agreed to pay $14 million to settle allegations by the U.S. Securities and Exchange Commission that its representatives in China bribed state-owned and state-controlled hospitals to...

To view the full article, register now.